Brevan Howard Capital Management’s Amgen AMGN Stock Holding History

Brevan Howard Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.8M	Buy	18,788 +13,668	+267%	+$4.68M	0.05%	259
2026 Q1	$1.8M	Buy	5,120 +2,308	+82%	+$823K	0.02%	598
2025 Q4	$921K	Sell	2,812 -1,931	-41%	-$613K	0.01%	805
2025 Q3	$1.34M	Sell	4,743 -13,968	-75%	-$4.05M	0.01%	766
2025 Q2	$5.22M	Sell	18,711 -3,345	-15%	-$948K	0.03%	354
2025 Q1	$6.87M	Buy	+22,056	New	+$6.51M	0.07%	94
2024 Q4	–	Sell	-3,749	Closed	-$1.21M	–	1021
2024 Q3	$1.21M	Buy	+3,749	New	+$1.23M	0.01%	392
2024 Q1	–	Sell	-922	Closed	-$266K	–	992
2023 Q4	$266K	Buy	+922	New	+$251K	﹤0.01%	771

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Brevan Howard Capital Management's AMGN Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Amgen (AMGN) stake by 267% in Q2 2026, buying an estimated $4.68M and bringing the position to 18,788 shares worth $6.8M. The position accounts for 0.05% of the portfolio, ranked #259.

Brevan Howard Capital Management first reported a position in AMGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $6.87M in Q1 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Brevan Howard Capital Management held 18,788 shares of Amgen worth $6.8M as of Q2 2026.
Brevan Howard Capital Management bought 13,668 Amgen shares in Q2 2026, an estimated $4.68M.
Amgen made up 0.05% of Brevan Howard Capital Management's portfolio in Q2 2026, its #259 holding.
Brevan Howard Capital Management first reported a position in Amgen in Q4 2023 and has held it in 8 quarters since.
Brevan Howard Capital Management's Amgen position peaked at $6.87M in Q1 2025.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.